References
- World Cancer Research Fund International. Worldwide data: world cancer statistics for the most common cancers [Internet]. London: World Cancer Research Fund International; c2015 [cited 2015 Aug 12]. Available from: http://www.wcrf.org/int/cancer-facts-figures/worldwide-data.
- Jung KW, Won YJ, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat 2015;47:127-41. https://doi.org/10.4143/crt.2015.060
- Zietman AL, DeSilvio ML, Slater JD, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005;294:1233-9. https://doi.org/10.1001/jama.294.10.1233
- Peeters ST, Heemsbergen WD, Koper PC, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006;24:1990-6. https://doi.org/10.1200/JCO.2005.05.2530
- Dearnaley DP, Jovic G, Syndikus I, et al. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 2014;15:464-73. https://doi.org/10.1016/S1470-2045(14)70040-3
- Kuban DA, Tucker SL, Dong L, et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:67-74. https://doi.org/10.1016/j.ijrobp.2007.06.054
- Eade TN, Hanlon AL, Horwitz EM, Buyyounouski MK, Hanks GE, Pollack A. What dose of external-beam radiation is high enough for prostate cancer? Int J Radiat Oncol Biol Phys 2007;68:682-9. https://doi.org/10.1016/j.ijrobp.2007.01.008
- Ray KJ, Sibson NR, Kiltie AE. Treatment of breast and prostate cancer by hypofractionated radiotherapy: potential risks and benefits. Clin Oncol (R Coll Radiol) 2015;27:420-6. https://doi.org/10.1016/j.clon.2015.02.008
- Tucker SL, Thames HD, Michalski JM, et al. Estimation of alpha/beta for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys 2011;81:600-5. https://doi.org/10.1016/j.ijrobp.2010.11.080
-
Miralbell R, Roberts SA, Zubizarreta E, Hendry JH. Dosefractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets:
${\alpha}/{\beta}$ = 1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys 2012;82:e17-24. https://doi.org/10.1016/j.ijrobp.2010.10.075 -
Proust-Lima C, Taylor JM, Secher S, et al. Confirmation of a low
${\alpha}/{\beta}$ ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeatedmeasures model for PSA dynamics. Int J Radiat Oncol Biol Phys 2011;79:195-201. https://doi.org/10.1016/j.ijrobp.2009.10.008 - Dolezel M, Odrazka K, Zouhar M, et al. Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer. Strahlenther Onkol 2015;191:338-46. https://doi.org/10.1007/s00066-014-0806-y
- Jani AB, Su A, Correa D, Gratzle J. Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields. Prostate Cancer Prostatic Dis 2007;10:82-6. https://doi.org/10.1038/sj.pcan.4500910
- National Comprehensive Cancer Network. NCCN guidelines for patients: prostate cancer [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2016 [cited 2016 Mar 17]. Available from: http://www.nccn.org/patients/guidelines/prostate/files/assets/common/downloads/files/prostate.pdf.
- Arcangeli S, Strigari L, Gomellini S, et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012;84:1172-8. https://doi.org/10.1016/j.ijrobp.2012.02.049
- Arcangeli G, Saracino B, Gomellini S, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010;78:11-8. https://doi.org/10.1016/j.ijrobp.2009.07.1691
- Huang EH, Pollack A, Levy L, et al. Late rectal toxicity: dosevolume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002;54:1314-21. https://doi.org/10.1016/S0360-3016(02)03742-2
- Yeoh E, Horowitz M, Russo A, et al. Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med 1993;95:397-406. https://doi.org/10.1016/0002-9343(93)90309-D
- Guckenberger M, Lawrenz I, Flentje M. Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT. Strahlenther Onkol 2014;190:48-53. https://doi.org/10.1007/s00066-013-0443-x
- Zelefsky MJ, Cowen D, Fuks Z, et al. Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma. Cancer 1999;85:2460-8. https://doi.org/10.1002/(SICI)1097-0142(19990601)85:11<2460::AID-CNCR23>3.0.CO;2-N
- Zelefsky MJ, Levin EJ, Hunt M, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008;70:1124-9. https://doi.org/10.1016/j.ijrobp.2007.11.044
- Teh BS, Mai WY, Augspurger ME, et al. Intensity modulated radiation therapy (IMRT) following prostatectomy: more favorable acute genitourinary toxicity profile compared to primary IMRT for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:465-72. https://doi.org/10.1016/S0360-3016(00)01474-7
- Zelefsky MJ, Chan H, Hunt M, Yamada Y, Shippy AM, Amols H. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J Urol 2006;176(4 Pt 1):1415-9. https://doi.org/10.1016/j.juro.2006.06.002
Cited by
- Defining the Optimal Time of Adaptive Replanning in Prostate Cancer Patients with Weight Change during Volumetric Arc Radiotherapy: A Dosimetric and Mathematical Analysis Using the Gamma Index vol.2017, pp.None, 2016, https://doi.org/10.1155/2017/4149591
- Treatment plan comparison between Tri-Co-60 magnetic-resonance image-guided radiation therapy and volumetric modulated arc therapy for prostate cancer vol.8, pp.53, 2017, https://doi.org/10.18632/oncotarget.20039